JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
PUT
Southern Company
SO
$106B
| $5.08M | ﹤0.01% |
79,700
| – | – |
|
2552
Cohen & Steers
CNS
$4.36B
| $5.08M | ﹤0.01% |
80,885
+27,936
| +53% | +$1.77M |
|
|
CRC
2553
PUT
DELISTED
California Resources Corporation
CRC
| $5.06M | ﹤0.01% |
+560,200
| New | +$4.54M |
|
2554
CRA International
CRAI
$1.07B
| $5.05M | ﹤0.01% |
92,652
+9,640
| +12% | +$468K |
|
2555
CALL
Trade Desk
TTD
$6.84B
| $5.04M | ﹤0.01% |
194,000
| – | – |
|
2556
CALL
NIO
NIO
$11.3B
| $5.03M | ﹤0.01% |
1,250,600
-200,000
| -14% | -$402K |
|
2557
Criteo S.A. Ordinary Shares
CRTO
$872M
| $5.02M | ﹤0.01% |
289,824
-180,283
| -38% | -$3.21M |
|
2558
CALL
Ascendis Pharma A/S
ASND
$16.8B
| $5.01M | ﹤0.01% |
+36,000
| New | +$4M |
|
|
2559
PUT
Ascendis Pharma A/S
ASND
$16.8B
| $5.01M | ﹤0.01% |
+36,000
| New | +$4M |
|
2560
Glaukos
GKOS
$11.2B
| $5M | ﹤0.01% |
91,863
+42,804
| +87% | +$2.6M |
|
|
PTLA
2561
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.98M | ﹤0.01% |
208,500
-1,500
| -0.7% | -$41.4K |
|
|
SRCL
2562
DELISTED
Stericycle Inc
SRCL
| $4.97M | ﹤0.01% |
77,951
-4,038
| -5% | -$239K |
|
2563
Vishay Precision Group
VPG
$908M
| $4.96M | ﹤0.01% |
145,996
-4,895
| -3% | -$164K |
|
2564
PUT
Allstate
ALL
$64.7B
| $4.96M | ﹤0.01% |
44,100
| – | – |
|
|
EIGR
2565
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.95M | ﹤0.01% |
11,070
+814
| +8% | +$289K |
|
|
EE
2566
DELISTED
El Paso Electric Company
EE
| $4.94M | ﹤0.01% |
72,828
+13,483
| +23% | +$908K |
|
2567
CALL
GoPro
GPRO
$117M
| $4.94M | ﹤0.01% |
1,138,700
| – | – |
|
2568
Tredegar Corp
TG
$281M
| $4.92M | ﹤0.01% |
220,278
+119,092
| +118% | +$2.5M |
|
|
AMRN
2569
Amarin Corp
AMRN
$297M
| $4.92M | ﹤0.01% |
11,464
+192
| +2% | +$72.9K |
|
2570
PUT
Verizon
VZ
$200B
| $4.91M | ﹤0.01% |
80,000
+10,000
| +14% | +$603K |
|
2571
Valmont Industries
VMI
$9.52B
| $4.9M | ﹤0.01% |
32,729
-15,920
| -33% | -$2.25M |
|
2572
Elbit Systems
ESLT
$36.5B
| $4.9M | ﹤0.01% |
31,581
-7,204
| -19% | -$1.17M |
|
|
AKS
2573
DELISTED
AK Steel Holding Corp
AKS
| $4.89M | ﹤0.01% |
1,486,237
-3,934,848
| -73% | -$10.9M |
|
2574
CALL
Philips
PHG
$26.2B
| $4.88M | ﹤0.01% |
125,808
| – | – |
|
|
2575
PUT
Philips
PHG
$26.2B
| $4.88M | ﹤0.01% |
125,808
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.